Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide Injectable Emulsion in Advanced Prostate Cancer
CTR20220814Phase 3Completed
- Sponsor
- Yida Biotechnology
- Start
- Apr 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Yida Biotechnology. Started Apr 2022; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20220814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220814.